Boston Scientific Corporation Share Price
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.76 USD | -0.09% |
|
+0.02% | +56.86% |
| 12-04 | Boston Scientific Insider Sold Shares Worth $633,917, According to a Recent SEC Filing | MT |
| 11-25 | Boston Scientific to Buy Intera Oncology | MT |
| Capitalization | 134B 127B 118B 105B 188B 11,342B 208B 1,463B 544B 4,652B 503B 492B 20,103B | P/E ratio 2024 * |
68.2x | P/E ratio 2025 * | 48x |
|---|---|---|---|---|---|
| Enterprise value | 141B 134B 124B 111B 198B 11,933B 219B 1,540B 572B 4,895B 529B 517B 21,150B | EV / Sales 2024 * |
8.5x | EV / Sales 2025 * | 7.4x |
| Free-Float |
84.69% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Boston Scientific Corporation
More recommendations
More press releases
More news
| 1 day | -0.37% | ||
| 1 week | +0.35% | ||
| Current month | +0.35% | ||
| 1 month | +6.35% | ||
| 3 months | +11.80% | ||
| 6 months | +19.88% | ||
| Current year | +57.37% |
1 week
89.62
91.34
1 month
85.0391.93
Current year
57.1191.93
1 year
54.3191.93
3 years
34.9891.93
5 years
24.1091.93
10 years
12.5691.93
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 59 | 31/10/2011 |
Daniel Brennan
DFI | Director of Finance/CFO | 58 | 30/12/2013 |
Jodi Eddy
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/06/2020 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 59 | 31/03/2009 |
Michael Mahoney
CHM | Chairman | 59 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 72 | 28/02/2014 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.26% | 12 M€ | +15.09% | - | |
| 1.98% | 1 M€ | +2.21% | - | |
| 1.75% | 20 M€ | +16.82% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.37% | +0.35% | +65.77% | +123.53% | 134B | ||
| -1.80% | -1.93% | +5.66% | -16.53% | 202B | ||
| -0.49% | +1.19% | +77.20% | +69.40% | 196B | ||
| -3.45% | -4.55% | +4.26% | -25.45% | 171B | ||
| -0.06% | +1.57% | -1.41% | -18.82% | 61.01B | ||
| -2.35% | +1.73% | +5.42% | -35.17% | 43.76B | ||
| -1.76% | -5.23% | -12.98% | -27.76% | 43.2B | ||
| -1.21% | +0.51% | +8.44% | -8.45% | 39.98B | ||
| -0.32% | -0.44% | +21.96% | - | 37.93B | ||
| -2.38% | -3.49% | +49.33% | -7.67% | 36.08B | ||
| Average | -1.40% | +0.81% | +22.36% | +5.90% | 96.47B | |
| Weighted average by Cap. | -1.45% | +1.21% | +29.38% | +19.36% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 16.58B 15.74B 14.64B 13.04B 23.33B 1,405B 25.76B 181B 67.35B 576B 62.27B 60.9B 2,489B | 18.62B 17.68B 16.45B 14.65B 26.21B 1,578B 28.93B 204B 75.65B 647B 69.94B 68.41B 2,796B |
| Net income | 1.98B 1.88B 1.75B 1.55B 2.78B 167B 3.07B 21.61B 8.03B 68.69B 7.42B 7.26B 297B | 2.84B 2.7B 2.51B 2.24B 4B 241B 4.42B 31.07B 11.55B 98.79B 10.68B 10.44B 427B |
| Net Debt | 6.98B 6.62B 6.16B 5.49B 9.82B 591B 10.84B 76.24B 28.33B 242B 26.2B 25.62B 1,047B | 3.89B 3.7B 3.44B 3.06B 5.48B 330B 6.05B 42.56B 15.82B 135B 14.62B 14.3B 585B |
More financial data
* Estimated data
Employees
48,000
Calendar
28/01/2025
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/24 | 90.67 $ | -0.19% | 2,172,465 |
| 04/12/24 | 90.84 $ | +0.41% | 3,507,289 |
| 03/12/24 | 90.47 $ | +0.04% | 3,192,033 |
| 02/12/24 | 90.43 $ | -0.25% | 3,388,073 |
| 29/11/24 | 90.66 $ | -0.10% | 3,446,971 |
Delayed Quote Nyse, December 05, 2024 at 03:43 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
90.84USD
Average target price
97.00USD
Spread / Average Target
+6.78%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition